Ziopharm Oncology
ZIOP
#8626
Rank
A$0.27 B
Marketcap
A$1.27
Share price
-0.88%
Change (1 day)
-77.07%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -A$0.12 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are A$3.73 Million. In 2020 the company made an earning of -A$0.12 Billion a decrease over its 2019 earnings that were of -A$84.23 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$0.12 Billion1.76%
2020-A$0.12 Billion38.89%
2019-A$84.23 Million7.33%
2018-A$78.48 Million0.77%
2017-A$77.88 Million-67.64%
2016-A$0.25 Billion37.64%
2015-A$0.18 Billion176.1%
2014-A$63.33 Million-24.63%
2013-A$84.02 Million-43.51%
2012-A$0.15 Billion43.09%
2011-A$0.11 Billion190.88%
2010-A$35.74 Million102.46%
2009-A$17.65 Million-52.68%
2008-A$37.3 Million-10.33%
2007-A$41.6 Million15.35%
2006-A$36.06 Million355.36%
2005-A$7.92 Million13788.35%
2004-A$0.06 Million9.27%
2003-A$0.06 Million-10.26%
2002-A$0.06 Million-59.35%
2001-A$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$13.06 B-10,154.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.74 Billion 465.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B-10,548.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-A$4.01 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA